EUVIMEDEUVIMED entdecken
Open Access

Simplified Summary of the fourth joint inter‐agency report on integrated analysis of antimicrobial agent consumption and occurrence of antimicrobial resistance in bacteria from humans and food‐producing animals in the EU/EEA (JIACRA IV, 2019–2021)

EFSA Journal · 2024-02 · 22 (2)

DOI: 10.2903/j.efsa.2024.p220201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EFSA Journal, 2024-02. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 1 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fourth joint inter-agency report on integrated analysis of antimicrobial consumption and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the European Union (JIACRA IV -2019-2021) Background • Antimicrobial resistance (AMR) is a major global threat to human and animal health.• The use and misuse of antimicrobials in humans and in food-producing animals are major drivers of AMR.Addressing AMR requires a coordinated effort from the human and animal sectors across the globe.• Antimicrobial-resistant bacterial infections are a serious health problem in Europe, causing over 35,000 deaths annually.This is comparable to the combined impact of influenza, tuberculosis and HIV/AIDS.Recent data show that antimicrobial-resistant bacteria are causing a growing number of infections and deaths in humans, particularly in healthcare settings.• In accordance with the European One Health Action Plan against Antimicrobial Resistance, the European Commission (EC) tasked the European Centre for Disease Prevention and Control (ECDC), the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA), to gather data on the link between antimicrobial consumption (AMC) and AMR in humans and food-producing animals.• This is the fourth Joint Interagency Antimicrobial Consumption and Resistance Analysis (JIACRA) report, primarily covering the period 2019-2021.The three previous JIACRA reports considered AMC and AMR data for a series of consecutive periods since 2011.What were ECDC, EFSA and EMA asked to do?• The EC tasked ECDC, EFSA and EMA to produce the fourth JIACRA report.The report presents results of data analyses that investigate possible associations between AMC in humans and foodproducing animals and the occurrence of AMR in bacteria in both sectors.The analyses also sought to identify significant trends in AMR and AMC and assess whether trends were concomitant. 'Complete susceptibility'or 'zero resistance' -is technically defined as susceptibility to all antimicrobial groups included in harmonised panels of antimicrobials addressed within the framework of a monitoring (panels are presented in the report).

Zitieren

APA

(2024). Simplified Summary of the fourth joint inter‐agency report on integrated analysis of antimicrobial agent consumption and occurrence of antimicrobial resistance in bacteria from humans and food‐producing animals in the EU/EEA (JIACRA IV, 2019–2021). EFSA Journal, 22(2). https://doi.org/10.2903/j.efsa.2024.p220201

Vancouver

Simplified Summary of the fourth joint inter‐agency report on integrated analysis of antimicrobial agent consumption and occurrence of antimicrobial resistance in bacteria from humans and food‐producing animals in the EU/EEA (JIACRA IV, 2019–2021). EFSA Journal. 2024;22(2). doi:10.2903/j.efsa.2024.p220201

BibTeX
@article{euvimed2024,
  title = {Simplified Summary of the fourth joint inter‐agency report on integrated analysis of antimicrobial agent consumption and occurrence of antimicrobial resistance in bacteria from humans and food‐producing animals in the EU/EEA (JIACRA IV, 2019–2021)},
  journal = {EFSA Journal},
  year = {2024},
  volume = {22},
  number = {2},
  doi = {10.2903/j.efsa.2024.p220201}
}
Kostenlos starten →